BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 34880120)

  • 1. Neuroendocrine Stress Axis-Dependence of Duloxetine Analgesia (Anti-Hyperalgesia) in Chemotherapy-Induced Peripheral Neuropathy.
    Staurengo-Ferrari L; Bonet IJM; Araldi D; Green PG; Levine JD
    J Neurosci; 2022 Jan; 42(3):405-415. PubMed ID: 34880120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duloxetine prevents bortezomib and paclitaxel large-fiber chemotherapy-induced peripheral neuropathy (LF-CIPN) in sprague dawley rats.
    Mansooralavi N; Khomula EV; Levine JD
    Mol Pain; 2023; 19():17448069231185694. PubMed ID: 37338165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of duloxetine response in patients with oxaliplatin-induced painful chemotherapy-induced peripheral neuropathy (CIPN): a secondary analysis of randomised controlled trial - CALGB/alliance 170601.
    Smith EM; Pang H; Ye C; Cirrincione C; Fleishman S; Paskett ED; Ahles T; Bressler LR; Le-Lindqwister N; Fadul CE; Loprinzi C; Shapiro CL;
    Eur J Cancer Care (Engl); 2017 Mar; 26(2):. PubMed ID: 26603828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sexual dimorphism in the contribution of neuroendocrine stress axes to oxaliplatin-induced painful peripheral neuropathy.
    Staurengo-Ferrari L; Green PG; Araldi D; Ferrari LF; Miaskowski C; Levine JD
    Pain; 2021 Mar; 162(3):907-918. PubMed ID: 32947545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analgesic Effects of Sokeikakketsuto on Chemotherapy-Induced Mechanical Allodynia and Cold Hyperalgesia in Rats.
    Nakamura H; Kawashiri T; Kobayashi D; Uchida M; Egashira N; Shimazoe T
    Biol Pharm Bull; 2021; 44(2):271-274. PubMed ID: 33518680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug treatment for chemotherapy-induced peripheral neuropathy in patients with pancreatic cancer.
    Sugimoto M; Takagi T; Suzuki R; Konno N; Asama H; Sato Y; Irie H; Okubo Y; Nakamura J; Takasumi M; Hashimoto M; Kato T; Kobashi R; Hikichi T; Ohira H
    Fukushima J Med Sci; 2022 Apr; 68(1):1-10. PubMed ID: 35197393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of Duloxetine on Oxaliplatin-induced Allodynia and Hyperalgesia in Rats.
    Wagner MA; Smith EML; Ayyash N; Toledo J; Rasheed Z; Holden JE
    Biol Res Nurs; 2024 Apr; 26(2):248-256. PubMed ID: 37902612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the Anti-Allodynic and Anti-Hyperalgesic Efficacy of a Glycine Transporter 2 Inhibitor Relative to Pregabalin, Duloxetine and Indomethacin in a Rat Model of Cisplatin-Induced Peripheral Neuropathy.
    Kuo A; Corradini L; Nicholson JR; Smith MT
    Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34202809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marked sexual dimorphism in neuroendocrine mechanisms for the exacerbation of paclitaxel-induced painful peripheral neuropathy by stress.
    Ferrari LF; Araldi D; Green PG; Levine JD
    Pain; 2020 Apr; 161(4):865-874. PubMed ID: 31917777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage Toll-like Receptor 9 Contributes to Chemotherapy-Induced Neuropathic Pain in Male Mice.
    Luo X; Huh Y; Bang S; He Q; Zhang L; Matsuda M; Ji RR
    J Neurosci; 2019 Aug; 39(35):6848-6864. PubMed ID: 31270160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of duloxetine in Japanese patients with chemotherapy-induced peripheral neuropathy: a pilot randomized trial.
    Hirayama Y; Ishitani K; Sato Y; Iyama S; Takada K; Murase K; Kuroda H; Nagamachi Y; Konuma Y; Fujimi A; Sagawa T; Ono K; Horiguchi H; Terui T; Koike K; Kusakabe T; Sato T; Takimoto R; Kobune M; Kato J
    Int J Clin Oncol; 2015 Oct; 20(5):866-71. PubMed ID: 25762165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment strategy of oxaliplatin-induced peripheral neuropathy: a retrospective, nationwide study.
    Yokoyama S; Nakagawa C; Hosomi K
    Support Care Cancer; 2022 Feb; 30(2):1765-1773. PubMed ID: 34595605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin-norepinephrine reuptake inhibitors for the management of chemotherapy-induced peripheral neuropathy.
    Aziz MT; Good BL; Lowe DK
    Ann Pharmacother; 2014 May; 48(5):626-32. PubMed ID: 24577146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombomodulin alfa prevents oxaliplatin-induced neuropathic symptoms through activation of thrombin-activatable fibrinolysis inhibitor and protein C without affecting anti-tumor activity.
    Minami T; Takeda M; Sata M; Kato H; Yano K; Sakai T; Tsujita R; Kawasaki K; Ito A
    Eur J Pharmacol; 2020 Aug; 880():173196. PubMed ID: 32416186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duloxetine Attenuates Paclitaxel-Induced Peripheral Nerve Injury by Inhibiting p53-Related Pathways.
    Lu Y; Zhang P; Zhang Q; Yang C; Qian Y; Suo J; Tao X; Zhu J
    J Pharmacol Exp Ther; 2020 Jun; 373(3):453-462. PubMed ID: 32238452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of pattern recognition receptors in chemotherapy-induced neuropathic pain.
    Araldi D; Khomula EV; Bonet IJM; Bogen O; Green PG; Levine JD
    Brain; 2024 Mar; 147(3):1025-1042. PubMed ID: 37787114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemoglobin, Body Mass Index, and Age as Risk Factors for Paclitaxel- and Oxaliplatin-Induced Peripheral Neuropathy.
    Mizrahi D; Park SB; Li T; Timmins HC; Trinh T; Au K; Battaglini E; Wyld D; Henderson RD; Grimison P; Ke H; Geelan-Small P; Marker J; Wall B; Goldstein D
    JAMA Netw Open; 2021 Feb; 4(2):e2036695. PubMed ID: 33587134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Participation of transient receptor potential vanilloid 1 in the analgesic effect of duloxetine for paclitaxel induced peripheral neuropathic pain.
    Wang J; Zhou F; Zhang S; Mao M; Feng S; Wang X
    Neurosci Lett; 2022 Mar; 773():136512. PubMed ID: 35149198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the publication of Clinical Guidelines for the Management of Chemotherapy-Induced Peripheral Neuropathy on the Administration Preferences of Oncology Specialists: Japanese Association of Supportive Care in Cancer.
    Hirayama Y; Yoshida Y; Mori M; Tamura K
    Jpn J Clin Oncol; 2020 Aug; 50(8):897-902. PubMed ID: 32424420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroendocrine mechanisms in oxaliplatin-induced hyperalgesic priming.
    Staurengo-Ferrari L; Araldi D; Green PG; Levine JD
    Pain; 2023 Jun; 164(6):1375-1387. PubMed ID: 36729863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.